ProShare Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,466
| Closed | -$10.5K | – | 1955 |
|
|
2023
Q3 | $10.5K | Buy |
+13,466
| New | +$10.5K | ﹤0.01% | 1804 |
|
|
2023
Q2 | – | Sell |
-10,077
| Closed | -$11K | – | 1850 |
|
|
2023
Q1 | $11K | Sell |
10,077
-1,884
| -16% | -$2.05K | ﹤0.01% | 1763 |
|
|
2022
Q4 | $17.5K | Sell |
11,961
-124
| -1% | -$181 | ﹤0.01% | 1811 |
|
|
2022
Q3 | $13K | Buy |
12,085
+1,361
| +13% | +$1.46K | ﹤0.01% | 1730 |
|
|
2022
Q2 | $18K | Sell |
10,724
-3,479
| -24% | -$5.84K | ﹤0.01% | 1773 |
|
|
2022
Q1 | $29K | Sell |
14,203
-5,112
| -26% | -$10.4K | ﹤0.01% | 2150 |
|
|
2021
Q4 | $72K | Sell |
19,315
-9,958
| -34% | -$37.1K | ﹤0.01% | 2239 |
|
|
2021
Q3 | $151K | Buy |
29,273
+4,753
| +19% | +$24.5K | ﹤0.01% | 1845 |
|
|
2021
Q2 | $104K | Buy |
24,520
+5,680
| +30% | +$24.1K | ﹤0.01% | 2287 |
|
|
2021
Q1 | $100K | Sell |
18,840
-2,165
| -10% | -$11.5K | ﹤0.01% | 2166 |
|
|
2020
Q4 | $113K | Buy |
+21,005
| New | +$113K | ﹤0.01% | 1973 |
|
|
2019
Q4 | – | Sell |
-22,483
| Closed | -$34K | – | 1791 |
|
|
2019
Q3 | $34K | Sell |
22,483
-1,380
| -6% | -$2.09K | ﹤0.01% | 1621 |
|
|
2019
Q2 | $96K | Sell |
23,863
-3,405
| -12% | -$13.7K | ﹤0.01% | 1536 |
|
|
2019
Q1 | $117K | Buy |
27,268
+1,324
| +5% | +$5.68K | ﹤0.01% | 1555 |
|
|
2018
Q4 | $149K | Sell |
25,944
-1,146
| -4% | -$6.58K | ﹤0.01% | 1427 |
|
|
2018
Q3 | $367K | Sell |
27,090
-516
| -2% | -$6.99K | ﹤0.01% | 1257 |
|
|
2018
Q2 | $328K | Sell |
27,606
-2,399
| -8% | -$28.5K | ﹤0.01% | 1332 |
|
|
2018
Q1 | $337K | Sell |
30,005
-1,479
| -5% | -$16.6K | ﹤0.01% | 1262 |
|
|
2017
Q4 | $210K | Buy |
+31,484
| New | +$210K | ﹤0.01% | 1617 |
|